ReviewJournal of hematology & oncology2022

Targeting p53-MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials.

Haohao Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.